NFASC and chronic inflammatory demyelinating polyradiculoneuropathy: defined seropositive CIDP as patients with antibodies against neurofascin, CNTN1 and Caspr1 and suggested these subgroups of patients had unique characteristics that distinguished them from patients with seronegative CIDP.